Sizoo Eefje M, Reijneveld Jaap C, Lagerwaard Frank J, Buter Jan, Taphoorn Martin J B, Hamer Philip C de Witt
VU Medisch Centrum, Afd. Neurologie, Amsterdam, The Netherlands.
Ned Tijdschr Geneeskd. 2010;154:A1367.
Watchful waiting has long been justified in the Netherlands for patients in whom a low-grade glioma is suspected. According to recent advances in knowledge it is clear that the course of a suspected low-grade glioma cannot be reliably determined by clinical characteristics, imaging or biopsy. Early resection of the tumour provides a histological diagnosis, the possibility of removing a source of epilepsy and postponement of tumour growth and progression. Alleviation of symptoms, sustained quality of life and cognition are at least as important an aim of treatment as survival and postponement of tumour progression. In our opinion, early resection should be strongly considered in every patient with a suspected low-grade glioma. However, radiotherapy or chemotherapy should only be considered early in the presence of unfavourable prognostic factors or persistent epilepsy. Each patient in whom a low-grade glioma is suspected should receive specific treatment advice from a neuro-oncological team.
长期以来,在荷兰,对于疑似患有低度恶性胶质瘤的患者,观察等待一直是合理的做法。根据最近的知识进展,很明显,无法通过临床特征、影像学或活检可靠地确定疑似低度恶性胶质瘤的病程。早期切除肿瘤可提供组织学诊断,消除癫痫源,并延缓肿瘤生长和进展。缓解症状、维持生活质量和认知至少与生存及延缓肿瘤进展一样,是治疗的重要目标。我们认为,对于每一位疑似患有低度恶性胶质瘤的患者,都应强烈考虑早期切除。然而,只有在存在不良预后因素或持续性癫痫的情况下,才应尽早考虑放疗或化疗。每一位疑似患有低度恶性胶质瘤的患者都应接受神经肿瘤学团队的具体治疗建议。